CPC A61K 38/45 (2013.01) [A61K 45/06 (2013.01); C12Y 207/0104 (2013.01)] | 19 Claims |
1. A method of treating hemolytic anemia in a subject, comprising administering to the subject about 10 mg/day, about 40 mg/day, about 100 mg/day, or about 200 mg/day of mitapivat or a pharmaceutically acceptable salt thereof and a moderate inducer of cytochrome P450 3A4/5 (CYP3A4/5).
|